Focus
Novo Nordisk
LATEST
Ozempic’s Sister Drug Reduces Cardiovascular Risk by 14 Percent in Large-Scale Trial
Learn about the study’s possible impact on treatment strategies.
|
Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
The company said it conducted tests on compounded drugs that claim to contain semaglutide and found ‘concerning levels of unknown impurities.’
|
FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
The contamination does not affect its popular weight loss drugs Wegovy and Ozempic, according to the company.
|
Ozempic’s Sister Drug Reduces Cardiovascular Risk by 14 Percent in Large-Scale Trial
Learn about the study’s possible impact on treatment strategies.
|
Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
The company said it conducted tests on compounded drugs that claim to contain semaglutide and found ‘concerning levels of unknown impurities.’
|
FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
The contamination does not affect its popular weight loss drugs Wegovy and Ozempic, according to the company.
|